Should I Buy LLY Stock in 2026?

Data-driven analysis and honest assessment for Eli Lilly & Co

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $927.03P/E: 39.3

Decision Score

4.3/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)3/10

High P/E of 39.3 indicates premium

Growth (20%)5/10

Slow growth of 0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)4/10

Low FCF yield of 2.7%

Insider Activity (10%)5/10

Balanced insider activity

Key Investment Metrics

Current Price

$927.03

P/E Ratio

39.32

Revenue Growth

0.4%

Profit Margin

0.3%

Market Cap

$809.1B

Dividend Yield

0.01%

How LLY Compares to Competitors

Understanding how LLY stacks up against peers helps inform your investment decision.

How LLY Compares to Peers

Upcoming Events for LLY

+5 Reasons TO Buy LLY

1. High gross margins of 83%

strong

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

2. Large-cap stability and market leadership

moderate

With market cap over $100B, this company has established leadership and resources to weather cycles.

-5 Reasons NOT to Buy LLY

1. Thin profit margins of 0.3%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

2. Premium valuation at 39x earnings

medium risk

P/E of 39 requires sustained growth to justify. Multiple compression risk exists.

3. Minimal revenue growth

low risk

Growth of 0.4% barely keeps pace with inflation.

Who Should Buy LLY?

Investment Profile

Risk Level

Medium

Recommended Holding Period

3-5 years

Best For:

    Not Suitable For:

    • Growth Investors

      Limited 0% growth may disappoint

    • Value Investors

      Premium P/E of 39 doesn't fit value criteria

    • Income-Focused Retirees

      Low 0.0% yield

    Consider These Alternatives

    If you're interested in LLY, compare these Health Care peers:

    Pro tip: Compare LLY directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for LLY

    Frequently Asked Questions

    What is LLY stock price today?

    LLY (Eli Lilly & Co) stock is trading at $927.03 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is LLY stock going up or down today?

    LLY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy LLY stock now?

    The decision to buy LLY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is LLY a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for LLY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is LLY stock overvalued or undervalued?

    LLY currently trades at a P/E ratio of 39.32, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LLY is fairly priced.

    What is LLY's P/E ratio?

    LLY has a price-to-earnings (P/E) ratio of 39.32, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

    What is LLY's market cap?

    LLY (Eli Lilly & Co) has a market capitalization of $809.09 billion, making it a large-cap stock.

    What is LLY's price to book ratio?

    LLY trades at a price-to-book (P/B) ratio of 30.47, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Eli Lilly & Co

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.